PHARMACY

Cannabis pharmacy premieres in U.K.

BY Antoinette Alexander

LONDON — Carun Pharmacy, the United Kingdom’s first cannabis pharmacy, officially opened its doors in May in Twickenham, London, offering consumers a range of health and beauty products that harness the healing powers of hemp.

Carun product offerings include Virgin Hemp Oil, which, according to the company, has a large range of health benefits and is the ideal replacement for traditional cooking oils; Hemp bio syrup, which is suitable for adults and children with respiratory problems, cough and cold; and Hemp Seed, which promotes a healthy metabolism when taken as part of a healthy balanced diet.

“I feel incredibly excited to be opening the first cannabis pharmacy in the United Kingdom. Carun products are made from a specially cultivated species of cannabis sativa called Carmagnola. The compounds called Cannabinoids, which act on Cannabinoid receptors on our cells surface, are very similar to those which [the] human body naturally produce in our Endocanabinoid system,” explained Michal Takac, Carun’s U.K. managing director. “These support our immune system, restore the balance and health of cells, as well as possess anti-inflammatory, antiseptic and antibiotic properties. But no … they will not and cannot make you high.” Unlike marijuana, which has a THC level of 20% to 30% (the psychoactive chemical that creates a “high”), Carun products only contain around 0.3%. With anti-inflammatory, antibacterial and hypoallergenic properties, the Carun line soothes and heals such skin conditions as rashes, allergies, psoriasis, eczema, wrinkles, stretch marks, bedsores, scars, burns, sunburn, and dry, cracked or sensitive skin, the company stated.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

Vote against trade bill continues debate over generic access

BY Michael Johnsen

WASHINGTON — The U.S. House of Representatives on Friday rejected the first of a series of trade bills, placing the Trans-Pacific Partnership trade agreement in jeapordy and ensuring a continued debate between branded and generic pharmaceutical manufacturers over the trade pact’s possible impact on the availability of generic drugs. 
 
“In today’s debate on the Trade Promotion Authority, members of the U.S. House of Representatives rightly expressed strong reservations about the Trans-Pacific Partnership,” Ralph Neas, president and CEO of the Generic Pharmaceutical Association, said on Friday. “As it stands now, TPP will make it harder for the U.S. generic industry to sell its products overseas. That is because the intellectual property provisions in TPP are designed to give longer protection to patented drugs and postpone the entry of cost-saving generic medicines. The U.S. generic industry cannot support a TPP that benefits only one side of the pharmaceutical industry, jeopardizing the right of patients in America and around the world to have timely access to affordable medicines.”
 
The New York Times recently reported that the Obama administration is no longer demanding protection for pharmaceutical prices under the trade agreement, which critics suggest will empower pharmaceutical manufacturers to command higher reimbursement rates. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

Target sells pharmacy business to CVS Health

BY Mike Troy

WOONSOCKET, R.I., and MINNEAPOLIS — Target plans to sell its pharmacy business to CVS Health for $1.9 billion and rebrand its nearly 1,700 prescription departments as CVS/pharmacy in a blockbuster deal that stunned the healthcare world.

In addition to the pharmacies, CVS Health also will acquire Target’s 80 clinic locations and rebrand them as MinuteClinic, moving the company closer to its goal of operating 1,500 clinics by 2017. The companies also announced plans to develop five to 10 small, flexible format stores during the next two years that will be branded as Target Express and contain a CVS Health pharmacy.

The transaction enables CVS Health to reach more patients, adding a new retail channel for its offerings, and expanding convenient options for consumers, according to a statement by the companies. Given CVS Health's success in growing its business, the relationship is expected to benefit Target's long-term traffic and sales growth.

It also enables Target to strengthen its focus on wellness as a signature category. Moving forward, enhanced efforts by Target will center on continuing to deliver products and experiences to help guests eat well, be active and find natural and clean label products, according to the companies.

"This strategic relationship with Target supports the highly complementary customer base, brand and culture we share," said Larry Merlo, CVS Health president and CEO. "When we introduced the new name for our company, CVS Health, we began a new era of growth with a broader healthcare focus and an appreciation of the rise of healthcare consumerism with consumer choice and accountability growing. This relationship with Target will provide consumers with expanded options and access to our unique healthcare services that lead to better health outcomes and lower overall healthcare costs.”

"At Target, we've talked a lot about the evolving preferences of our guests and this partnership demonstrates that we're committed to putting them at the forefront of everything we do," said Brian Cornell, Target chairman and CEO. "By partnering with CVS Health, we will offer our guests industry leading healthcare services, and at the same time, sharpen our focus on elevating the way we deliver wellness products and experiences to our guests."

The deal is consistent with each company's stated goals of investing in core businesses that help drive growth, according to the companies. CVS Health expects the transaction to generate significant sales and prescription volumes upon closing, and to generate significant operating profit over the long term.

The transaction will allow Target to continue offering a traffic-driving business in its stores and deliver a differentiated experience in support of its wellness efforts. Target expects to realized after-tax proceeds from the deal of approximately $1.2 billion, which it expects to deploy in support of its long-standing capital priorities, including share repurchase. Upon closing, the companies said in-store changes at Target locations will be rolled out over a period of several months thereafter, as CVS Health and Target work to ensure the smoothest possible transition for all pharmacy and clinic patients.

CVS Health said it is committed to offering the approximately 14,000 in-store Target healthcare professionals comparable positions with CVS Health as part of the transition, while Target said it would evaluate the business impact and related support needs at its headquarters locations.

Target will continue to manage its OTC and other front-end businesses, though CVS Health will certainly influence that business going forward.

“[This CVS Health deal] is very complementary to our vision of wellness,” Cornell told analysts Monday morning. “We now have a strategic partner that brings scale, expertise, unique capabilities and certainly experience in this space to make sure it complements the things we're going to focus on from a wellness standpoint as we think about bringing better assortment, improved brands to the Target guests. Our commitment to wellness will only accelerate as part of this and we'll continue to make sure that we have the right products.”

And the sky's the limit, Cornell added, there are no limitations or restrictions on how OTC and wellness will be merchandised in the vacinity of the newly branded CVS Health pharmacies.
 
"We'll be focusing on our core strengths," Cornell said, "making great choices fronm an assortment standpoint, making sure that we have an outstanding in-store presentation and continuing to make sure that we localize and personalize how we interact with our guests."

keyboard_arrow_downCOMMENTS

Leave a Reply

D.BIERNBAUM says:
Jun-15-2015 02:30 pm

This is a very smart strategy for both Target and CVS, for so many reasons, on so many levels. Maybe the smartest partnership in the consumer goods retail industry to happen in the past five years or so.

TRENDING STORIES